25
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The advantage of channeling nucleotides for very processive functions

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Nucleoside triphosphate (NTP)s, like ATP (adenosine 5’-triphosphate) and GTP (guanosine 5’-triphosphate), have long been considered sufficiently concentrated and diffusible to fuel all cellular ATPases (adenosine triphosphatases) and GTPases (guanosine triphosphatases) in an energetically healthy cell without becoming limiting for function. However, increasing evidence for the importance of local ATP and GTP pools, synthesised in close proximity to ATP- or GTP-consuming reactions, has fundamentally challenged our view of energy metabolism. It has become evident that cellular energy metabolism occurs in many specialised ‘microcompartments’, where energy in the form of NTPs is transferred preferentially from NTP-generating modules directly to NTP-consuming modules. Such energy channeling occurs when diffusion through the cytosol is limited, where these modules are physically close and, in particular, if the NTP-consuming reaction has a very high turnover, i.e. is very processive. Here, we summarise the evidence for these conclusions and describe new insights into the physiological importance and molecular mechanisms of energy channeling gained from recent studies. In particular, we describe the role of glycolytic enzymes for axonal vesicle transport and nucleoside diphosphate kinases for the functions of dynamins and dynamin-related GTPases.

          Related collections

          Most cited references178

          • Record: found
          • Abstract: found
          • Article: not found

          The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants.

          The three-dimensional structure of the complex between human H-Ras bound to guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain of the human GTPase-activating protein p120GAP (GAP-334) in the presence of aluminum fluoride was solved at a resolution of 2.5 angstroms. The structure shows the partly hydrophilic and partly hydrophobic nature of the communication between the two molecules, which explains the sensitivity of the interaction toward both salts and lipids. An arginine side chain (arginine-789) of GAP-334 is supplied into the active site of Ras to neutralize developing charges in the transition state. The switch II region of Ras is stabilized by GAP-334, thus allowing glutamine-61 of Ras, mutation of which activates the oncogenic potential, to participate in catalysis. The structural arrangement in the active site is consistent with a mostly associative mechanism of phosphoryl transfer and provides an explanation for the activation of Ras by glycine-12 and glutamine-61 mutations. Glycine-12 in the transition state mimic is within van der Waals distance of both arginine-789 of GAP-334 and glutamine-61 of Ras, and even its mutation to alanine would disturb the arrangements of residues in the transition state.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The GTPase superfamily: a conserved switch for diverse cell functions.

            Proteins that bind and hydrolyse GTP are being discovered at a rapidly increasing rate. Each of these many GTPases acts as a molecular switch whose 'on' and 'off' states are triggered by binding and hydrolysis of GTP. Conserved structure and mechanism in myriad versions of the switch--in bacteria, yeast, flies and vertebrates--suggest that all derive from a single primordial protein, repeatedly modified in the course of evolution to perform a dazzling variety of functions.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Structure of mitochondrial ADP/ATP carrier in complex with carboxyatractyloside.

              ATP, the principal energy currency of the cell, fuels most biosynthetic reactions in the cytoplasm by its hydrolysis into ADP and inorganic phosphate. Because resynthesis of ATP occurs in the mitochondrial matrix, ATP is exported into the cytoplasm while ADP is imported into the matrix. The exchange is accomplished by a single protein, the ADP/ATP carrier. Here we have solved the bovine carrier structure at a resolution of 2.2 A by X-ray crystallography in complex with an inhibitor, carboxyatractyloside. Six alpha-helices form a compact transmembrane domain, which, at the surface towards the space between inner and outer mitochondrial membranes, reveals a deep depression. At its bottom, a hexapeptide carrying the signature of nucleotide carriers (RRRMMM) is located. Our structure, together with earlier biochemical results, suggests that transport substrates bind to the bottom of the cavity and that translocation results from a transient transition from a 'pit' to a 'channel' conformation.
                Bookmark

                Author and article information

                Journal
                F1000Res
                F1000Res
                F1000Research
                F1000Research
                F1000Research (London, UK )
                2046-1402
                18 May 2017
                2017
                : 6
                : 724
                Affiliations
                [1 ]ESPCI - Paris, PSL Research University, Paris, F-75005, France
                [2 ]CNRS, UMR8249, Paris, F-75005, France
                [3 ]Laboratory of Fundamental and Applied Bioenergetics (LBFA), and SFR Environmental and Systems Biology (BEeSy), U1055, University Grenoble Alpes, Grenoble, 38058, France
                [4 ]Inserm-U1055, Grenoble, F-38058, France
                [5 ]Institute of Neuroscience, University of Oregon, Eugene, OR, 97401, USA
                [6 ]INRA, UR1037 LPGP, Campus de Beaulieu, Rennes, F-35000, France
                [7 ]Department of Biochemistry, University of Geneva, Geneva, CH-1211, Switzerland
                [8 ]Swiss National Centre for Competence in Research Programme Chemical Biology, Geneva, CH-1211, Switzerland
                [9 ]Institut Curie, Paris, F-75248, France
                [10 ]PSL Research University, Paris, F-75005, France
                [11 ]CNRS, UMR144, Paris, F-75248, France
                [12 ]Sorbonne Universités, UPMC Univ Paris 06, INSERM, UMRS938, Saint-Antoine Research Center, Paris, F-75012, France
                [13 ]AP-HP, Hospital Tenon, Service de Biochimie et Hormonologie, Paris, F-75020, France
                [1 ]Institute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary
                [1 ]Yale University School of Medicine, Department of Neuroscience, Program in Cellular Neuroscience, Neurodegeneration and Repair, Kavli Institute for Neuroscience, New Haven, CT, USA
                [1 ]Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA
                Author notes

                *Contributed equally to the manuscript

                DZ and MB prepared and wrote the first draft of the manuscript, except the evolution section. TD and JB wrote the paragraph concerning evolution. US wrote the paragraph concerning ATP channeling and creatine kinase. AR and PC brought important corrections to the first draft. All authors were involved in the revision of the draft manuscript and have agreed to the final content.

                Competing interests: MB is an Associate Professor and Hospital Practitioner in Cell Biology at the Faculty of Medicine from the University Pierre & Marie Curie. DZ is an Inserm investigator. No other competing interests were disclosed.

                Competing interests: No competing interests were disclosed.

                Competing interests: No competing interests were disclosed.

                Competing interests: No competing interests were disclosed.

                Author information
                http://orcid.org/0000-0002-0052-8011
                http://orcid.org/0000-0003-1159-5911
                http://orcid.org/0000-0001-5126-8785
                http://orcid.org/0000-0002-9355-8227
                http://orcid.org/0000-0001-6494-5722
                Article
                10.12688/f1000research.11561.1
                5473427
                28663786
                4305e0a2-4a75-4995-a878-811da03ff877
                Copyright: © 2017 Zala D et al.

                This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 15 May 2017
                Funding
                Funded by: Fondation pour la Recherche Médicale
                Award ID: FRM DPM20121125557
                Funded by: Groupement des Entreprises Françaises contre le Cancer
                Award ID: GEFLUC R16170DD/RAK16044DDA
                Research by the authors reviewed here was supported by the Fondation pour la Recherche Médicale, France (FRM DPM20121125557 to US and MB) and the Groupement des Entreprises Françaises contre le Cancer (GEFLUC R16170DD/RAK16044DDA to MB).
                Categories
                Review
                Articles
                Cell Signaling
                Membranes & Sorting

                glycolysis,oxidative phosphorylation,bioenergetics,atp,gtp,dynamin,nucleoside diphosphate kinase,creatine kinase

                Comments

                Comment on this article